Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
Track recession signals with key labor market updates and GDP forecasts while seeing the impacts of tariffs day on economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback